Search by Drug Name or NDC

NDC 50474-0991-80 ZILBRYSQ 40 mg/mL Details

ZILBRYSQ 40 mg/mL

ZILBRYSQ is a SUBCUTANEOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by UCB, Inc.. The primary component is ZILUCOPLAN.

MedlinePlus Drug Summary

Zilucoplan injection is used to treat myasthenia gravis (MG; a disorder of the nervous system that causes muscle weakness) in certain adult patients. Zilucoplan is in a class of medications called compliment inhibitors. It works by stopping the compliment system from damaging the acetylcholine receptors on the muscles, which is what causes the symptoms of MG.

Related Packages: 50474-0991-80
Last Updated: 04/14/2024
MedLinePlus Full Drug Details: Zilucoplan Injection

Product Information

NDC	50474-0991
Product ID	50474-991_7126c28c-eece-4e9d-b46f-9e203195e759
Associated GPIs
GCN Sequence Number	085406
GCN Sequence Number Description	zilucoplan sodium SYRINGE 23/0.574ML SUBCUT
HIC3	M0L
HIC3 Description	COMPLEMENT INHIBITORS
GCN	54877
HICL Sequence Number	049273
HICL Sequence Number Description	ZILUCOPLAN SODIUM
Brand/Generic	Brand
Proprietary Name	ZILBRYSQ
Proprietary Name Suffix	n/a
Non-Proprietary Name	zilucoplan
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	INJECTION, SOLUTION
Route	SUBCUTANEOUS
Active Ingredient Strength	40
Active Ingredient Units	mg/mL
Substance Name	ZILUCOPLAN
Labeler Name	UCB, Inc.
Pharmaceutical Class	Complement Inhibitor [EPC], Complement Inhibitors [MoA]
DEA Schedule	n/a
Marketing Category	NDA
Application Number	NDA216834
Listing Certified Through	2024-12-31

Package

NDC 50474-0991-80 (50474099180)

Pricing Information	N/A
NDC Package Code	50474-991-80
Billing NDC	50474099180
Package	4 CARTON in 1 BOX (50474-991-80) / 7 SYRINGE, GLASS in 1 CARTON / .574 mL in 1 SYRINGE, GLASS
Marketing Start Date	2024-01-03
NDC Exclude Flag	N